XML 27 R13.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stockholders' Deficit | 6 Months Ended
--- | ---
Dec. 31, 2018
Stockholders' Equity Note [Abstract] |
Stockholders' Equity Note Disclosure [Text Block] | Note 7. Stockholders’ Deficit Changes in Stockholders’ Deficit For changes in stockholders’ deficit for the six months ended December 31, 2018, please refer to the unaudited condensed consolidated statement of stockholders’ deficit. The following table presents changes in stockholders’ deficit for the three months ended December 31, 2018:
|  |  |  |  |  |  |  | Additional |  |  |  |  |  | Total |
|  | Common Stock |  |  | Paid-in |  |  | Accumulated |  |  | Stockholders' |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Deficit |
Balances, September 30, 2018 |  |  | 62,166,309 |  |  | $ | 62,168 |  |  | $ | 91,043,622 |  |  | $ | (97,548,971 | ) |  | $ | (6,443,181 | )
Stock-based compensation |  |  | - |  |  |  | - |  |  |  | 815,418 |  |  |  | - |  |  |  | 815,418 |
Fair value of warrants issued to consultants |  |  | - |  |  |  | - |  |  |  | 1,501 |  |  |  | - |  |  |  | 1,501 |
Shareholder surrender of shares for no consideration |  |  | (299,990 | ) |  |  | (299 | ) |  |  | 299 |  |  |  | - |  |  |  | - |
Net loss |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (4,161,432 | ) |  |  | (4,161,432 | )
Balances, December 31, 2018 |  |  | 61,866,319 |  |  | $ | 61,869 |  |  | $ | 91,860,840 |  |  | $ | (101,710,403 | ) |  | $ | (9,787,694 | )
Changes in stockholders’ deficit for each of the three months ended September 30, 2017 and December 31, 2017 are as follows:
|  |  |  |  |  |  |  | Additional |  |  |  |  |  | Total |
|  | Common Stock |  |  | Paid-in |  |  | Accumulated |  |  | Stockholders' |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Deficit |
Balances, June 30, 2017 |  |  | 49,228,640 |  |  | $ | 49,230 |  |  | $ | 72,800,699 |  |  | $ | (64,321,962 | ) |  | $ | 8,527,967 |
Issuance of common stock, net of issuance costs of $60,000 |  |  | 4,500,000 |  |  |  | 4,500 |  |  |  | 4,435,500 |  |  |  |  |  |  |  | 4,440,000 |
Stock-based compensation |  |  | - |  |  |  | - |  |  |  | 1,507,699 |  |  |  | - |  |  |  | 1,507,699 |
Fair value of warrants issued to consultants |  |  | - |  |  |  | - |  |  |  | 14,847 |  |  |  | - |  |  |  | 14,847 |
Net loss |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (6,684,612 | ) |  |  | (6,684,612 | )
Balances, September 30, 2017 |  |  | 53,728,640 |  |  |  | 53,730 |  |  |  | 78,758,745 |  |  |  | (71,006,574 | ) |  |  | 7,805,901 |
Stock-based compensation |  |  | - |  |  |  | - |  |  |  | 1,194,029 |  |  |  | - |  |  |  | 1,194,029 |
Fair value of warrants issued to consultants |  |  | - |  |  |  | - |  |  |  | 520,455 |  |  |  | - |  |  |  | 520,455 |
Commitment fee for issuance of common stock |  |  | 344,669 |  |  |  | 345 |  |  |  | (345 | ) |  |  | - |  |  |  | - |
Net loss |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (5,718,587 | ) |  |  | (5,718,587 | )
Balances, December 31, 2017 |  |  | 54,073,309 |  |  | $ | 54,075 |  |  | $ | 80,472,884 |  |  | $ | (76,725,161 | ) |  | $ | 3,801,798 |
Since its inception, the Company has not declared or paid any dividends. Series AA Preferred Stock Exclusivity Payment In December 2018, two New Investors expressed interest in investing in the Company and affirmed their intent to enter into exclusive diligence and negotiations regarding a potential equity financing (“Transaction”). In exchange for the receipt of a total of $1.5 million ("Exclusivity Payment"), the Company entered into an exclusivity agreement ("Exclusivity") with the New Investors. Pursuant to the terms of the Exclusivity, until the earlier to occur of: (i) the execution of a definitive agreement regarding a Transaction; (ii) the New Investors terminating the Exclusivity; or (iii) December 21, 2018, the Company agreed to cease any and all discussions and negotiations with all other third parties. In the event that both or either New Investor elected not to enter into a Transaction, then at such New Investors' sole election, it had the ability to either: (a) request that the Company refund the applicable Exclusivity Payment; or (b) elect to convert the applicable Exclusivity Payment into shares of the Company's Common Stock at a price per share to be agreed upon. As discussed in Note 11, on January 7, 2019, the New Investors decided to proceed with consummation of the Transaction whereby closing occurred on January 30, 2019. Since the Exclusivity Payment was refundable at the New Investors’ option, it is classified as a liability in the accompanying unaudited condensed consolidated balance sheet as of December 31, 2018. Since the Transaction closed on January 30, 2019, the Exclusivity Payment did not require existing working capital which results in classification as a long-term liability as of December 31, 2018.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration